AVITA Medical Inc (NASDAQ:RCEL)
| 11.25 Delayed Data As of 3:59pm ET |  +0.59 / +5.53%Today’s Change | 6.29 Today|||52-Week Range 21.70 | +70.45% Year-to-Date |
Latest RCEL News | Press Releases
| Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance Nov 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.66 |
| Today’s open | 10.70 |
| Day’s range | 10.59 - 11.28 |
| Volume | 5,954 |
| Average volume (3 months) | 174,155 |
| Market cap | $277.2M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +9.02% |
| Earnings growth (this year) | -28.94% |
| Earnings growth (next 5 years) | +25.77% |
| Revenue growth (last year) | +17.75% |
| P/E ratio | NM |
| Price/Sales | 4.79 |
| Price/Book | 3.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | +0.06 | +4.09% |
| AFFYAffymax Inc | 0.00 | 0.00% |
| KZRKezar Life Sciences ... | +0.00 | +0.29% |
| --Zero Gravity Solutio... | 0.00 | 0.00% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$26.7M |
| Net profit margin | -77.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Valencia, California |
Forecasts
